This hypothesis is sustained by a study conducted by Lui et al. where 5.5% of COVID-19 patients who initially had negative anti-thyroperoxidase (anti-TPO) antibodies, tested positive at a median of three months post-infection when their thyroid function was reassessed [93]. The gene discussed is TPO; the disease is infection.